Status:
RECRUITING
A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices: The Novel Cor-IS Technology Will Also be Evaluated
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Acute Coronary Syndromes
Flow Mediated Dilation
Eligibility:
All Genders
18-85 years
Brief Summary
A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices....
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)
- Capability of providing written informed consent
- Patients able to comply with the follow-up schedule of the study
Exclusion
- Patients with acute coronary syndromes classified as MINOCA, or type II myocardial infarction
- Patients with rare acute coronary syndrome types, such as spontaneous coronary artery dissection or Takotsubo syndrome
- Patients with congenital heart disease
- Age \> 85 years
- Patients with end stage chronic kidney disease
- Patients with active malignancy or autoimmune diseases which limit their survival
- Patients with expected survival \< 1 year due to other reasons
- Suboptimal echocardiographic windows
- Inability to provide written consent
- Inability to comply with the follow-up schedule of the study
- Pregnancy
- Use of intravenous drugs
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06890013
Start Date
June 1 2024
End Date
November 1 2026
Last Update
July 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ippokratio General Hospital
Thessaloniki, Greece, 54642